| UBS MSCI JAPAN SOCIALLY RESPONSIBLE UCITS ETF HUSD ACC | RVI JAPÓN | 52,28% | 95,27% | 155,96% | · |
| GAM MULTISTOCK JAPAN SPECIAL SITUATIONS B USD HEDGED | RENT. ABSOLUTA. | 52,27% | 67,67% | 112,64% | 266,93% |
| HSBC GIF GLOBAL EMERGING MARKETS EQUITY IC USD | RVI EMERGENTES | 52,27% | 77,89% | 47,98% | 159,87% |
| MAN JAPAN COREALPHA EQUITY I H EUR | RVI JAPÓN | 52,25% | 117,22% | · | 417,30% |
| CT (LUX) GLOBAL EMERGING MARKET EQUITIES ZE EUR | RVI EMERGENTES | 52,21% | 83,25% | 21,90% | · |
| IMGP JAPAN OPPORTUNITIES C USD HP | RVI JAPÓN VALOR | 52,20% | 96,69% | 185,62% | 311,49% |
| SCHRODER ISF EMERGING MARKETS MULTI-ASSET A MDIS ZAR (HEDGED) | MIXTO FLEXIBLE | 52,20% | 59,08% | -13,21% | · |
| UBS (LUX) EQUITY SICAV - GLOBAL EMERGING MARKETS OPPORTUNITY (USD) I-A1-ACC | RVI EMERGENTES CRECIMIENTO | 52,20% | 81,30% | 37,21% | 153,20% |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) USD | RVI BIOTECNOLOGÍA | 52,16% | 23,24% | -21,33% | · |
| LO FUNDS - ASIA HIGH CONVICTION (USD) N CAP | RVI ASIA EX-JAPÓN | 52,15% | 90,03% | 39,16% | · |
